Fluorocurcumins as Cyclooxygenase-2 Inhibitor: Molecular Docking, Pharmacokinetics and Tissue Distribution in Mice

Author： Padhye Subhash Banerjee Sanjeev Chavan Deepak Pandye Shubhangini Swamy K.Venkateswara Ali Shadan Li Jing Dou Q. Sarkar Fazlul

Publisher： Springer Publishing Company

ISSN： 0724-8741

Source： Pharmaceutical Research, Vol.26, Iss.11, 2009-11, pp. : 2438-2445

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Pharmacokinetics of Rofecoxib: A Specific Cyclo-Oxygenase-2 Inhibitor

By Davies N.M.

Clinical Pharmacokinetics, Vol. 42, Iss. 6, 2003-01 ,pp. : 545-556

Adis International

Access to resources Recommend Favorite

Clinical Pharmacokinetics and Pharmacodynamics of Celecoxib: A Selective Cyclo-Oxygenase-2 Inhibitor

By Davies N.M.

Clinical Pharmacokinetics, Vol. 38, Iss. 3, 2000-03 ,pp. : 225-242

Adis International

Access to resources Recommend Favorite

Rofecoxib, a selective cyclooxygenase-2 (COX-2) inhibitor potentiates the anticonvulsant activity of tiagabine against pentylenetetrazol-induced convulsions in mice

By Dhir A. Kulkarni S.

Inflammopharmacology, Vol. 14, Iss. 5-6, 2006-12 ,pp. : 222-225

Springer Publishing Company

Access to resources Recommend Favorite

The Role of P-Glycoprotein in the Pharmacokinetics and Tissue Distribution of a Hepatitis C Virus Protease Inhibitor

Drug Metabolism Letters, Vol. 3, Iss. 4, 2009-12 ,pp. : 290-295

Bentham Science Publishers

Access to resources Recommend Favorite

Sunitinib–ibuprofen drug interaction affects the pharmacokinetics and tissue distribution of sunitinib to brain, liver, and kidney in male and female mice differently

Fundamental & Clinical Pharmacology, Vol. 29, Iss. 4, 2015-08 ,pp. : 404-416

John Wiley & Sons Inc

Access to resources Recommend Favorite